Clinical Trial Update: Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing antiviral efficacy and acceptability of mouth rinses to inactivate COVID-19; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: COVID19, Coronavirus Infection | Phase 2 | Status: TERMINATED | Results posted: 2022-02-16